Malignant Testicular Neoplasm — Trials

Malignant Testicular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 26
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: University Health Network, Toronto
Termination share: 35.3%
Trials / 1,000 deaths: 80.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06814496	Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors(RABBIT)	recruiting	Phase 1 / Phase 2	30	University of ArizonaOTHER	1	Sep 22, 2026	clinicaltrials
NCT01366144	Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction	active not recruiting	Phase 1	94	National Cancer Institute (NCI)NIH	1	Sep 4, 2026